The FDA has approved the first treatment for Ebola
Lab-made antibodies marshal an immune response and curb the virus’s ability to infect cells
A United Nations peacekeeper has his shoes cleaned before leaving an Ebola treatment center in the Congo in 2019. A clinical trial carried out at centers like these from 2018 to 2019 found that Inmazeb, a monoclonal antibody cocktail, is effective in treating Ebola.
ALEXIS HUGUET/AFP/Getty Images